219 related articles for article (PubMed ID: 8555206)
1. Synthesis and structure determination by NMR of a putative vacuolar targeting peptide and model of a proteinase inhibitor from Nicotiana alata.
Nielsen KJ; Hill JM; Anderson MA; Craik DJ
Biochemistry; 1996 Jan; 35(2):369-78. PubMed ID: 8555206
[TBL] [Abstract][Full Text] [Related]
2. The three-dimensional solution structure by 1H NMR of a 6-kDa proteinase inhibitor isolated from the stigma of Nicotiana alata.
Nielsen KJ; Heath RL; Anderson MA; Craik DJ
J Mol Biol; 1994 Sep; 242(3):231-43. PubMed ID: 8089844
[TBL] [Abstract][Full Text] [Related]
3. The solution structure of C1-T1, a two-domain proteinase inhibitor derived from a circular precursor protein from Nicotiana alata.
Schirra HJ; Scanlon MJ; Lee MC; Anderson MA; Craik DJ
J Mol Biol; 2001 Feb; 306(1):69-79. PubMed ID: 11178894
[TBL] [Abstract][Full Text] [Related]
4. A novel two-chain proteinase inhibitor generated by circularization of a multidomain precursor protein.
Lee MC; Scanlon MJ; Craik DJ; Anderson MA
Nat Struct Biol; 1999 Jun; 6(6):526-30. PubMed ID: 10360353
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
6. Selective removal of individual disulfide bonds within a potato type II serine proteinase inhibitor from Nicotiana alata reveals differential stabilization of the reactive-site loop.
Schirra HJ; Guarino RF; Anderson MA; Craik DJ
J Mol Biol; 2010 Jan; 395(3):609-26. PubMed ID: 19925809
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of Eucommia antifungal peptide: a novel structural model distinct with a five-disulfide motif.
Huang RH; Xiang Y; Tu GZ; Zhang Y; Wang DC
Biochemistry; 2004 May; 43(20):6005-12. PubMed ID: 15147184
[TBL] [Abstract][Full Text] [Related]
8. Different legumin protein domains act as vacuolar targeting signals.
Saalbach G; Jung R; Kunze G; Saalbach I; Adler K; Müntz K
Plant Cell; 1991 Jul; 3(7):695-708. PubMed ID: 1841724
[TBL] [Abstract][Full Text] [Related]
9. Proteinase inhibitors in Nicotiana alata stigmas are derived from a precursor protein which is processed into five homologous inhibitors.
Atkinson AH; Heath RL; Simpson RJ; Clarke AE; Anderson MA
Plant Cell; 1993 Feb; 5(2):203-13. PubMed ID: 8453302
[TBL] [Abstract][Full Text] [Related]
10. Folding of the presequence of yeast pAPI into an amphipathic helix determines transport of the protein from the cytosol to the vacuole.
Martinez E; Jimenez MA; Seguí-Real B; Vandekerckhove J; Sandoval IV
J Mol Biol; 1997 Apr; 267(5):1124-38. PubMed ID: 9150401
[TBL] [Abstract][Full Text] [Related]
11. Conformational analysis of a set of peptides corresponding to the entire primary sequence of the N-terminal domain of the ribosomal protein L9: evidence for stable native-like secondary structure in the unfolded state.
Luisi DL; Wu WJ; Raleigh DP
J Mol Biol; 1999 Mar; 287(2):395-407. PubMed ID: 10080901
[TBL] [Abstract][Full Text] [Related]
12. Two reactive site locations and structure-function study of the arrowhead proteinase inhibitors, A and B, using mutagenesis.
Xie ZW; Luo MJ; Xu WF; Chi CW
Biochemistry; 1997 May; 36(19):5846-52. PubMed ID: 9153425
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional structure and molecular modelling of C1- inhibitor.
Perkins SJ
Behring Inst Mitt; 1993 Dec; (93):63-80. PubMed ID: 8172587
[TBL] [Abstract][Full Text] [Related]
14. Characterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions.
Zhou GP; Troy FA
Glycobiology; 2003 Feb; 13(2):51-71. PubMed ID: 12626407
[TBL] [Abstract][Full Text] [Related]
15. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
16. Structural similarities between the N-terminal domain of Clostridium pasteurianum hydrogenase and plant-type ferredoxins.
Kümmerle R; Atta M; Scuiller J; Gaillard J; Meyer J
Biochemistry; 1999 Feb; 38(6):1938-43. PubMed ID: 10026275
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of the epidermal growth factor domain of P-selectin.
Freedman SJ; Sanford DG; Bachovchin WW; Furie BC; Baleja JD; Furie B
Biochemistry; 1996 Oct; 35(43):13733-44. PubMed ID: 8901515
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel four-domain member of the proteinase inhibitor II family from the stigmas of Nicotiana alata.
Miller EA; Lee MC; Atkinson AH; Anderson MA
Plant Mol Biol; 2000 Jan; 42(2):329-33. PubMed ID: 10794532
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of Impatiens balsamina antimicrobial protein (Ib-AMP1).
Patel SU; Osborn R; Rees S; Thornton JM
Biochemistry; 1998 Jan; 37(4):983-90. PubMed ID: 9454588
[TBL] [Abstract][Full Text] [Related]
20. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]